Inspectors at the US Food and Drug Administration (FDA) say lack of data integrity, transparency, record retention, and inadequate controls are some of the most common issues they see during ...
The U.S. Food and Drug Administration has flagged data integrity, manufacturing and maintenance lapses at one of Dabur ...
The Food and Drug Administration's (FDA) drug review arm has proposed withdrawing approval for Amgen Inc.’s AMGN Tavneos (avacopan), citing concerns over data integrity, lack of proven effectiveness, ...
The US Food and Drug Administration (FDA) has just released its long-awaited Warning Letter to Sun Pharmaceuticals following a 483 and import alert announced earlier this year. And as the letter ...
The European Medicines Agency recommended that CSL Ltd.’s drug Tavneos be pulled from the market after finding it was ...
The FDA recently announced that it had identified “significant data integrity and study conduct concerns” in various bioequivalence studies conducted by the India-based contract research organization, ...
The EMA has started a review of Amgen Inc.’s Tavneos (avacopan) after questions were raised about the integrity of the data in the Advocate study that the agency assessed when granting approval of the ...
Amgen has denied a request by the FDA to voluntarily withdraw its rare disease drug Tavneos from the market, the company said Tuesday as it presented quarterly financial results. Amgen explained that ...
The "Data Integrity Auditor Masterclass Training Course (Apr 22nd - Apr 23rd, 2026)" training has been added to ResearchAndMarkets.com's offering. Data integrity has received more attention than ever ...
By Puyaan Singh June 29 (Reuters) - The New England Journal of Medicine on Monday retracted an article on a pivotal clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results